Literature DB >> 24519049

[Study on miR-490-5p and miR-363 as novel biomarkers for the diagnosis of colorectal cancer].

Xuehu Xu1, Xiaobing Wu, Shangbiao Wu, Qingping Jiang, Haibo Liu, Rong Chen, Yan Sun.   

Abstract

OBJECTIVE: To identify dysregulated microRNA(miRNA) that can act as novel biomarker for colorectal cancer screening.
METHODS: Real time-polymerase chain reaction was used to detect the expression profile of miRNA in tumor and paired normal tissues, and the significant dysregulated miRNA was examined by non-paired t-test. Receiver operating characteristic(ROC) curve was performed to evaluate the specificity and sensitivity of miR-363 and miR-490-5p as biomarkers to discriminate colorectal cancer patients from normal person.
RESULTS: Seven-three dysregulated miRNAs were found in male samples, of which 6 miRNAs were up-regulated and other 67 miRNAs were down-regulated, while 42 dysregulated miRNAs were found in female samples, of which 5 were up-regulated and 37 were down-regulated in tumor tissues compared with normal tissues. Among above dysregulated miRNAs, 33 miRNAs had significant differences, besides, dysregulated expression level of 10 of 33 miRNAs was over 5 folds in male and female as well as mixed samples.
CONCLUSIONS: The expression pattern in female is different from that in male. miR-363 and miR-490-5p possess the potential in screening colorectal cancer patients from healthy people.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24519049

Source DB:  PubMed          Journal:  Zhonghua Wei Chang Wai Ke Za Zhi        ISSN: 1671-0274


  6 in total

1.  Role of deregulated microRNAs in non-small cell lung cancer progression using fresh-frozen and formalin-fixed, paraffin-embedded samples.

Authors:  Yahong Wang; Jie Chen; Ziying Lin; Jun Cao; Haili Huang; Yun Jiang; Huijuan He; Lawei Yang; Nina Ren; Gang Liu
Journal:  Oncol Lett       Date:  2015-11-25       Impact factor: 2.967

2.  How interacting pathways are regulated by miRNAs in breast cancer subtypes.

Authors:  Claudia Cava; Antonio Colaprico; Gloria Bertoli; Gianluca Bontempi; Giancarlo Mauri; Isabella Castiglioni
Journal:  BMC Bioinformatics       Date:  2016-11-08       Impact factor: 3.169

3.  Expression of RUNX3 gene and miR-363 in colorectal cancer and the relationship with clinicopathological features.

Authors:  Guofeng Li
Journal:  Oncol Lett       Date:  2019-07-05       Impact factor: 2.967

4.  Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing.

Authors:  Chun-Hui Lai; Xu-Zhi Liang; Xiu-Yun Liang; Sheng-Jun Ma; Jun-Guo Li; Ming-Fang Shi; Xu Zhu; Hui-Hua Lan; Jiang-Hui Zeng
Journal:  Biomed Res Int       Date:  2019-10-15       Impact factor: 3.411

5.  Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.

Authors:  Ying Shi; Zhibao Liu
Journal:  J Cell Mol Med       Date:  2020-06-20       Impact factor: 5.310

Review 6.  MicroRNA-490-3p and -490-5p in carcinogenesis: Separate or the same goal?

Authors:  Yin Li; Dongmei Tian; Hao Chen; Yuanting Cai; Sang Chen; Shiwei Duan
Journal:  Oncol Lett       Date:  2021-07-22       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.